Immediate Impact
15 standout
Citing Papers
Prostate Cancer
2025 Standout
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
Works of Marniza Saad being referenced
Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marniza Saad | 235 | 152 | 67 | 74 | 50 | 399 | |
| Austin J. Iovoli | 172 | 187 | 53 | 83 | 56 | 395 | |
| Markus Glatzer | 186 | 170 | 61 | 64 | 32 | 445 | |
| Myra Robinson | 137 | 112 | 41 | 150 | 59 | 418 | |
| Kevin Diao | 234 | 200 | 33 | 91 | 35 | 400 | |
| Joseph A. Miccio | 178 | 164 | 46 | 112 | 43 | 401 | |
| Jordan A. Holmes | 175 | 114 | 28 | 41 | 49 | 419 | |
| Nirav S. Kapadia | 143 | 134 | 68 | 84 | 42 | 426 | |
| Dayssy A. Diaz | 108 | 142 | 49 | 110 | 43 | 358 | |
| Yvan Coscas | 177 | 205 | 43 | 55 | 37 | 453 | |
| Abhishek Kumar | 195 | 178 | 38 | 71 | 36 | 383 |
All Works
Login with ORCID to disown or claim papers
Loading papers...